吉林中医药2018，Vol.38Issue(6)：652-656,5.DOI:10.13463/j.cnki.jlzyy.2018.06.009
补肾健骨类中成药治疗骨质疏松症的Meta分析
Meta-analysis of Bushen Jiangu Chinese medicine in treating osteoporosis
摘要
Abstract
Objective To evaluate the clinical effect of three groups of Bushen Jiangu Chinese medicine in the treatment of osteoporosis.Methods The topic group uses the computer retrieval method, including SCI, Chinese journal full text database (CNKI), Cochrane library, EMbase, Wanfang and other Chinese and English databases, the retrieval period as of April 2017. A randomized controlled literature (RCTs) for the treatment of osteoporosis in Chinese medicine for Kidney-Nourishing Chinese Medicine was searched. The research group uses RevMan 5.3 software to conduct Meta analysis of data.Results Twenty-four RCTs (8 in each group) were included, involving 2423 subjects. Meta analysis showed that compared with the three groups of proprietary Chinese medicines, in the bone density (BMD) and the efficiency of the epimedium and psoralen-based proprietary Chinese medicine (Xian ling gu bao capsule), the treatment group is better than the control group (MD = 0.09, 95％ CI 0.05～ 0.14,P<00001; RR = 1.41, 95％ CI 1.24～ 1.61,P<0.00001); In the immune index (blood ALP). There was no statistically significant difference between the three groups.Conclusion The clinical efficacy of proprietary Chinese medicine (Xianlinggubao capsule), which is mainly composed of epimedium and psoralen, in the treatment of osteoporosis is the most positive in the three groups.关键词
补肾健骨/中成药/骨质疏松症/Meta分析Key words
Bushen Jiangu/Chinese medicine/osteoporosis/Meta analysis分类
医药卫生引用本文复制引用
王微,刘佳..补肾健骨类中成药治疗骨质疏松症的Meta分析[J].吉林中医药,2018,38(6):652-656,5.基金项目
吉林省卫生计生委青年科技骨干培养计划项目(2016Q051) （2016Q051）
吉林省中医药管理局科技项目(2017181) （2017181）
长春中医 药大学"百青计划". （）
